CompletedPhase 4NCT04320316
A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)
Studying Epidermal nevus syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- Hussein Abdul-Latif, MD, MDUniversity of Alabama at Birmingham
- Intervention
- Crysvita (burosumab-twza) Treatment(drug)
- Enrollment
- 1 enrolled
- Eligibility
- MALE
- Timeline
- 2020 – 2021
Study locations (1)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
Collaborators
Ultragenyx Pharmaceutical Inc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04320316 on ClinicalTrials.gov